Inhibikase Therapeutics to Report First Quarter Financial Results on May 15, 2023
- Monday, May 8, 2023, 7:11
- PR Newswire
- Add a comment
BOSTON and ATLANTA, May 8, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease, Parkinson’s-related disorders and…
About the Author
admin has written 21729 stories on this site.